Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis
Authors
Keywords
-
Journal
POSTGRADUATE MEDICAL JOURNAL
Volume -, Issue -, Pages postgradmedj-2021-139939
Publisher
BMJ
Online
2021-06-04
DOI
10.1136/postgradmedj-2021-139939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
- (2021) Julie Gorham et al. PLoS One
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
- (2020) Joseph T Wu et al. LANCET
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
- (2020) Qingxian Cai et al. ALLERGY
- Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
- (2020) Abinit Saha et al. ARCHIVES OF MEDICAL RESEARCH
- Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome
- (2020) Jared Radbel et al. CHEST
- Using IL‐2R/lymphocytes for predicting the clinical progression of patients with COVID‐19
- (2020) H. Hou et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
- (2020) Hin Chu et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-6: Relevance for immunopathology of SARS-CoV-2
- (2020) E.O. Gubernatorova et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
- (2020) Mingkai Tan et al. IMMUNOLOGY
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID‐19
- (2020) Yong Gao et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study
- (2020) Dan Sun et al. World Journal of Pediatrics
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- COVID-19 cytokine storm: the interplay between inflammation and coagulation
- (2020) Ricardo J Jose et al. Lancet Respiratory Medicine
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort
- (2020) Egon Burian et al. Journal of Clinical Medicine
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The cytokine storm of COVID-19: a spotlight on prevention and protection
- (2020) Lucie Pearce et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
- (2020) Zhe Zhu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
- (2020) Bingwen Liu et al. JOURNAL OF AUTOIMMUNITY
- Tocilizumab in patients with severe COVID‐19: A single‐center observational analysis
- (2020) John P Knorr et al. JOURNAL OF MEDICAL VIROLOGY
- The Association of Interleukin‐6 value, Interleukin inhibitors and Outcomes of Patients with COVID‐19 in New York City
- (2020) Tetsuro Maeda et al. JOURNAL OF MEDICAL VIROLOGY
- Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
- (2020) Andrew Ip et al. PLoS One
- Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study
- (2020) G Rojas-Marte et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19
- (2020) Zeming Liu et al. Frontiers in Pharmacology
- Laboratory biomarkers associated with COVID-19 severity and management
- (2020) S. Keddie et al. CLINICAL IMMUNOLOGY
- Cytokine prediction of mortality in COVID19 patients
- (2020) Mathilda Mandel et al. CYTOKINE
- A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer
- (2020) Carole Nagant et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Relationship between chest CT manifestations and immune response in COVID-19 patients
- (2020) Susu He et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Prediction of adverse clinical outcomes in patients with coronavirus disease 2019
- (2020) Si Shi et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Associations between serum amyloid A, interleukin‐6, and COVID‐19: A cross‐sectional study
- (2020) Qian Liu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
- (2020) Francesco Perrone et al. Journal of Translational Medicine
- Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020
- (2020) Hong Sun et al. MEDICAL SCIENCE MONITOR
- Selection of an Optimal Combination Panel to Better Triage COVID-19 Hospitalized Patients
- (2020) Yueting Tang et al. Journal of Inflammation Research
- Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
- (2020) Hasan Satış et al. CYTOKINE
- Association of interleukin-6 level with morbidity and mortality in patients with coronavirus disease 2019 (COVID-19)
- (2020) Jiali Zhou et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Predictors of Coronavirus Disease 2019 Severity: A Retrospective Study of 64 Cases
- (2020) Huihuang Huang et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Prediction of the Severity of the Coronavirus Disease and Its Adverse Clinical Outcomes
- (2020) Xiaohui Liu et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Peripheral blood inflammatory markers in predicting prognosis in patients with COVID‐19. Some differences with influenza A
- (2020) Yan Zhao et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis
- (2016) Gustav Nilsonne et al. PLoS One
- Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time
- (2015) Misty R. Jenkins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome
- (2015) Loredana Cifaldi et al. Arthritis & Rheumatology
- Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
- (2013) M. L. DeDiego et al. JOURNAL OF VIROLOGY
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now